| Disease | Target Count | P-value |
|---|---|---|
| ovarian cancer | 8520 | 1.5e-06 |
| nasopharyngeal carcinoma | 1058 | 1.8e-06 |
| ependymoma | 4679 | 1.2e-05 |
| cystic fibrosis | 1696 | 1.4e-04 |
| medulloblastoma, large-cell | 6241 | 5.8e-04 |
| ductal carcinoma in situ | 1745 | 1.9e-03 |
| osteosarcoma | 7950 | 2.6e-03 |
| breast carcinoma | 1638 | 3.2e-03 |
| invasive ductal carcinoma | 2951 | 3.4e-03 |
| pituitary cancer | 1972 | 3.9e-03 |
| atypical teratoid/rhabdoid tumor | 357 | 5.0e-03 |
| intraductal papillary-mucinous adenoma (IPMA) | 2955 | 5.6e-03 |
| intraductal papillary-mucinous carcinoma (IPMC) | 2989 | 1.0e-02 |
| adrenocortical carcinoma | 1428 | 1.5e-02 |
| subependymal giant cell astrocytoma | 2287 | 2.1e-02 |
| intraductal papillary-mucinous neoplasm (IPMN) | 3291 | 3.3e-02 |
| Disease | log2 FC | p |
|---|---|---|
| adrenocortical carcinoma | -1.324 | 1.5e-02 |
| atypical teratoid/rhabdoid tumor | 1.100 | 5.0e-03 |
| breast carcinoma | -1.600 | 3.2e-03 |
| cystic fibrosis | -1.174 | 1.4e-04 |
| ductal carcinoma in situ | -1.100 | 1.9e-03 |
| ependymoma | 1.300 | 1.2e-05 |
| intraductal papillary-mucinous adenoma (... | 1.700 | 5.6e-03 |
| intraductal papillary-mucinous carcinoma... | 1.900 | 1.0e-02 |
| intraductal papillary-mucinous neoplasm ... | 1.500 | 3.3e-02 |
| invasive ductal carcinoma | -1.300 | 3.4e-03 |
| medulloblastoma, large-cell | -1.100 | 5.8e-04 |
| nasopharyngeal carcinoma | -1.100 | 1.8e-06 |
| osteosarcoma | -1.681 | 2.6e-03 |
| ovarian cancer | -1.600 | 1.5e-06 |
| pituitary cancer | 1.100 | 3.9e-03 |
| subependymal giant cell astrocytoma | 1.341 | 2.1e-02 |
| Accession | A6NGC4 |
| Symbols |
MAPTGLLVAGASFLAFRGLHWGLRRLPTPESAARDRWQWWNLCVSLAHSLLSGTGALLGLSLYPQMAADP 1 - 70 IHGHPRWALVLVAVSVGYFLADGADLLWNQTLGKTWDLLCHHLVVVSCLSTAVLSGHYVGFSMVSLLLEL 71 - 140 NSACLHLRKLLLLSRQAPSLAFSVTSWASLATLALFRLVPLGWMSLWLFRQHHQVPLALVTLGGIGLVTV 141 - 210 GIMSIILGIRILVNDVLQSRPHPPSPGHEKTRGTRTRRDNGPVTSNSSTLSLKD 211 - 264 //
